Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPENING structured insulin management study in type 2 diabetes
ChiCTR-TRC-11001317Phase 4Completed
- Sponsor
- Bayer
- Start
- Mar 2011
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of biphasic insulin human in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Bayer. Primary endpoint: Change in HbA1c from baseline to endpoint. Started Mar 2011; status: completed.
02
Drugs
biphasic insulin human
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR-TRC-11001317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001317.